Energetic cost of breathing, body composition, and pulmonary function in horses with recurrent airway obstruction.
D000316:Adrenergic alpha-Agonists / Q000008:administration & dosage / Q000627:therapeutic use; D000336:Aerosols; D000402:Airway Obstruction / Q000188:drug therapy / Q000503:physiopathology* / Q000662:veterinary*; D000818:Animals; D001823:Body Composition / Q000502:physiology*; D001993:Bronchodilator Agents / Q000008:administration & dosage / Q000627:therapeutic use; D002153:Calorimetry, Indirect; D002245:Carbon Dioxide / Q000097:blood; D002908:Chronic Disease; D004548:Elasticity; D004734:Energy Metabolism / Q000502:physiology*; D005260:Female; D006734:Horse Diseases / Q000188:drug therapy / Q000503:physiopathology*; D006736:Horses / Q000502:physiology*; D006993:Hypnotics and Sedatives / Q000494:pharmacology; D008168:Lung / Q000503:physiopathology*; D008297:Male; D010100:Oxygen / Q000097:blood; D010805:Physical Conditioning, Animal / Q000502:physiology; D012008:Recurrence; D012129:Respiratory Function Tests; D015656:Respiratory Mechanics / Q000502:physiology*; D014991:Xylazine / Q000008:administration & dosage / Q000627:therapeutic use
D000316:Adrenergic alpha-Agonists; D000336:Aerosols; D001993:Bronchodilator Agents; D006993:Hypnotics and Sedatives; D002245:Carbon Dioxide; D014991:Xylazine; D010100:Oxygen